BioUtah Events

Back to Search

DiscGenics

Pharmaceuticals

Industry Member

About

DiscGenics is a biotechnology company developing advanced spinal stem cell therapeutics to treat patients with diseases of the intervertebral disc.

Membership Type

Industry Member

Contacts

Primary

Mr. Anthony Mangum MBA

Senior Analyst: Finance & Operations

Scott Butters

Controller

Dr. Isaac Erickson PhD

Development Engineer

Flagg Flanagan

President/CEO

Nancy Rose

Senior Human Resources Manager

Lindsey Saxon

Branding

Dr. Lara Silverman PhD

Manager R&D

Jamie Strate

Bob Wynalek

Chief Operating & Commercialization Officer

Powered By GrowthZone

A Special Thanks To Our Elite Members